CytoMed Therapeutics (GDTC) Total Non-Current Liabilities (2021 - 2026)
CytoMed Therapeutics (GDTC) posted Total Non-Current Liabilities of $325,696 for Q4 2025, up 3.8% from $313,745 a year earlier.
Powered by 
Analysis
CytoMed Therapeutics (GDTC) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, CytoMed Therapeutics' Total Non-Current Liabilities came in at $323,088, up 3.4% from FY2024.
- Annual Total Non-Current Liabilities shows a four-year compound annual growth rate of -5.9% (FY2021 to FY2025).
- In prior years, CytoMed Therapeutics' Total Non-Current Liabilities was $312,423 in FY2024 (+2.9%), $303,714 in FY2023 (-12.0%), $345,058 in FY2022 (-16.4%) and $412,749 in FY2021.
- Quarterly Total Non-Current Liabilities has run from a low of $302,034 in Q4 2023 to a high of $431,769 in Q2 2025 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in three of the last four quarters, with growth averaging 2.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | CytoMed Therapeutics | 9.94 Mn | -1.15 Mn | - | 391,715.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 391,715.00 |
| Dec 31, 2025 | 325,696.18 |
| Jun 30, 2025 | 431,769.00 |
| Dec 31, 2024 | 313,744.88 |
| Jun 30, 2024 | 390,896.00 |
| Dec 31, 2023 | 302,033.65 |
| Jun 30, 2023 | 431,195.00 |
| Dec 31, 2022 | 342,653.15 |
| Dec 31, 2021 | 408,558.52 |
API Access
CytoMed Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GDTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GDTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GDTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();